vs
亚玛芬体育（AS）与CLOVER HEALTH INVESTMENTS, CORP.（CLOV）财务数据对比。点击上方公司名可切换其他公司
亚玛芬体育的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.4倍（$1.1B vs $749.2M），CLOVER HEALTH INVESTMENTS, CORP.净利率更高（3.6% vs 1.8%，领先1.8%）
亚玛芬体育是芬兰跨国运动装备企业，总部位于赫尔辛基，成立于1950年。早年为涉足烟草贸易、航运、出版等领域的多元化工业集团，后逐步转型专注于体育用品的生产与营销，现有员工超9700人，2018年起成为中国安踏体育旗下子公司。
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
AS vs CLOV — 直观对比
营收规模更大
AS
是对方的1.4倍
$749.2M
净利率更高
CLOV
高出1.8%
1.8%
损益表 — Q1 FY2024 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $749.2M |
| 净利润 | $19.0M | $27.3M |
| 毛利率 | 52.8% | — |
| 营业利润率 | 12.4% | 3.6% |
| 净利率 | 1.8% | 3.6% |
| 营收同比 | — | 62.0% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.05 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCLOV
| Q1 26 | — | $749.2M | ||
| Q4 25 | — | $487.7M | ||
| Q3 25 | — | $496.6M | ||
| Q2 25 | — | $477.6M | ||
| Q1 25 | — | $462.3M | ||
| Q4 24 | — | $337.0M | ||
| Q3 24 | — | $331.0M | ||
| Q2 24 | — | $356.3M |
净利润ASCLOV
| Q1 26 | — | $27.3M | ||
| Q4 25 | — | $-49.3M | ||
| Q3 25 | — | $-24.4M | ||
| Q2 25 | — | $-10.6M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | — | $-22.1M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $7.4M |
毛利率ASCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 30.3% |
营业利润率ASCLOV
| Q1 26 | — | 3.6% | ||
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | -4.9% | ||
| Q2 25 | — | -2.2% | ||
| Q1 25 | — | -0.3% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | — | -2.7% | ||
| Q2 24 | — | 2.0% |
净利率ASCLOV
| Q1 26 | — | 3.6% | ||
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | -4.9% | ||
| Q2 25 | — | -2.2% | ||
| Q1 25 | — | -0.3% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | — | -2.8% | ||
| Q2 24 | — | 2.1% |
每股收益（稀释后）ASCLOV
| Q1 26 | — | $0.05 | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $177.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $339.4M |
| 总资产 | — | $697.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASCLOV
| Q1 26 | — | $177.6M | ||
| Q4 25 | — | $78.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $194.5M | ||
| Q3 24 | — | $288.0M | ||
| Q2 24 | — | $254.8M |
股东权益ASCLOV
| Q1 26 | — | $339.4M | ||
| Q4 25 | — | $308.7M | ||
| Q3 25 | — | $340.9M | ||
| Q2 25 | — | $344.2M | ||
| Q1 25 | — | $336.1M | ||
| Q4 24 | — | $341.1M | ||
| Q3 24 | — | $342.2M | ||
| Q2 24 | — | $324.9M |
总资产ASCLOV
| Q1 26 | — | $697.7M | ||
| Q4 25 | — | $541.0M | ||
| Q3 25 | — | $559.7M | ||
| Q2 25 | — | $575.0M | ||
| Q1 25 | — | $583.7M | ||
| Q4 24 | — | $580.7M | ||
| Q3 24 | — | $653.0M | ||
| Q2 24 | — | $674.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.3M | — |
| 自由现金流经营现金流 - 资本支出 | $92.2M | — |
| 自由现金流率自由现金流/营收 | 8.8% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | 6.02× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | $-66.9M | ||
| Q3 25 | — | $12.1M | ||
| Q2 25 | — | $5.4M | ||
| Q1 25 | — | $-16.3M | ||
| Q4 24 | — | $34.8M | ||
| Q3 24 | — | $50.0M | ||
| Q2 24 | — | $44.8M |
自由现金流ASCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | $-69.0M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | $-16.5M | ||
| Q4 24 | — | $33.3M | ||
| Q3 24 | — | $49.6M | ||
| Q2 24 | — | $44.4M |
自由现金流率ASCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | -14.1% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | -3.6% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 12.5% |
资本支出强度ASCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% |
现金转化率ASCLOV
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AS
| Americas2 | $409.6M | 39% |
| EMEA1 | $356.9M | 34% |
| Greater China3 | $205.6M | 20% |
| Asia Pacific4 | $78.2M | 7% |
CLOV
暂无分部数据
